Moreover, indices such as reduced glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) exhibited amplified activities in DLA cells and murine serum post AgNPs-CGA-BSA treatment, positing a prospective therapeutic avenue for T-cell lymphoma (Tamanna et al., 2022). The gene discussed is CAT; the disease is T-cell non-Hodgkin lymphoma.